BiotechTube
Home/Algok Bio/Andy (Bumjin) Kim, Ph.D.
A(

Andy (Bumjin) Kim, Ph.D.

Vice President, Co-Founder

Algok Bio

Therapeutic Areas

Oncology

Algok Bio Pipeline

DrugIndicationPhase
IdetrexedOvarian CancerPhase 1b
Anti-TM4SF4 AntibodyNot Specified (Oncology)Preclinical

Leadership Team at Algok Bio

SC
Sung Chul (S.C.) Kim, Ph.D.
President, Co-Founder
View full Algok Bio profile